GT BIOPHARMA, INC. Product Warranty Accrual, Current
GT BIOPHARMA, INC. (GTBP) had Product Warranty Accrual, Current of $0 as of 2017-12-31, per its 10-K filed 2018-03-01.
Discontinued › Notes › Payables and Accruals › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:ProductWarrantyAccrualClassifiedCurrent · last filed 2018-03-01
- 2017-12-31: Product Warranty Accrual, Current $0.00.
- 2017-09-30: Product Warranty Accrual, Current $0.00.
- 2017-06-30: Product Warranty Accrual, Current $964.00K.
- 2017-03-31: Product Warranty Accrual, Current $528.00K.
| Period end | Product Warranty Accrual, Current | Product Warranty Accrual, Current as first filed |
|---|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-03-01 | |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $964.00K 10-Q · filed 2017-08-11 | |
| 2017-03-31 | $528.00K 10-Q · filed 2017-04-28 | |
| 2016-12-31 | $417.00K 10-K · filed 2018-03-01 | |
| 2016-09-30 | $184.00K 10-Q/A · filed 2018-02-28 | |
| 2016-06-30 | $492.00K 10-Q/A · filed 2018-02-28 | |
| 2016-03-31 | $4.79M 10-Q/A · filed 2018-02-28 | |
| 2015-12-31 | $33.27M 10-K/A · filed 2018-02-28 | $44.53M 10-K · filed 2016-03-30 |
| 2015-09-30 | $11.35M 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $13.30M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $39.70M 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $21.58M 10-K/A · filed 2018-02-28 | |
| 2014-09-30 | $4.94M 10-Q · filed 2015-01-08 | |
| 2014-06-30 | $230.00K 10-Q · filed 2015-01-08 | |
| 2014-03-31 | $214.00K 10-Q · filed 2015-01-08 | |
| 2013-12-31 | $109.00K 10-K · filed 2015-03-31 | |
| 2013-09-30 | $13.00K 10-Q · filed 2014-12-17 | |
| 2013-06-30 | $3.00K 10-Q · filed 2014-12-12 | |
| 2013-03-31 | $18.00K 10-Q · filed 2014-12-10 | |
| 2012-12-31 | $1.38M 10-K · filed 2015-01-08 | |
| 2012-09-30 | $514.00K 10-Q · filed 2012-11-21 | |
| 2012-06-30 | $514.00K 10-Q/A · filed 2012-09-13 | |
| 2012-03-31 | $303.00K 10-Q · filed 2012-05-21 | |
| 2011-12-31 | $158.00K 10-K · filed 2014-11-18 | |
| 2011-09-30 | $290.00K 10-Q · filed 2011-11-21 | |
| 2011-06-30 | $980.00K 10-Q/A · filed 2011-09-12 | |
| 2010-12-31 | $1.01M 10-K · filed 2012-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |